Latest CRDF reports update at 2024-05-02: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Cardiff Oncology CRDF

$ 3.18 0.0%

Cardiff Oncology Balance Sheet 2011-2024 | CRDF

Annual Balance Sheet Cardiff Oncology

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-19.5 M	-13.6 M	-8.82 M	-130 M	-8.47 M	-11.5 M	-6.89 M	2.62 M	-51 M	-12.3 M	-25.3 M	-10.8 M	-700 K
Long Term Debt	1.46 M	2.04 M	2.57 M	-	-	-	-	14.2 M	11.2 M	13.1 M	323 K	-	-
Long Term Debt Current	691 K	675 K	551 K	860 K	865 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	451 K	993 K	1.12 M	1.83 M	16.4 M	14.5 M	16.1 M	4.75 M	8.77 M	3.84 M
Total Current Liabilities	10.4 M	7.81 M	6.56 M	6.12 M	4.78 M	2.97 M	3.95 M	7.8 M	8.2 M	4.49 M	2.01 M	730 K	-
Total Liabilities	11.9 M	9.85 M	9.13 M	6.57 M	5.78 M	4.09 M	5.78 M	24.2 M	22.7 M	20.5 M	6.76 M	9.5 M	5.27 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-340 M	-298 M	-260 M	-231 M	-209 M	-192 M	-173 M	-148 M	-109 M	-81.4 M	-67 M	-55.2 M	-43.6 M
Total Assets	81.6 M	116 M	150 M	135 M	13.1 M	14.2 M	12.3 M	44 M	71.4 M	28.9 M	27.2 M	11.7 M	1.04 M
Cash and Cash Equivalents	21.7 M	16.3 M	11.9 M	131 M	10.2 M	11.5 M	8.23 M	13.9 M	67.5 M	27.3 M	25.8 M	10.8 M	700 K
Book Value	69.7 M	106 M	140 M	128 M	7.31 M	10.1 M	6.51 M	19.8 M	48.7 M	8.35 M	20.4 M	2.17 M	-4.23 M
Total Shareholders Equity	69.7 M	106 M	140 M	128 M	7.31 M	10.1 M	6.51 M	19.8 M	48.7 M	8.35 M	20.4 M	2.17 M	-4.23 M

All numbers in USD currency

Quarterly Balance Sheet Cardiff Oncology

	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	1.3 M	1.46 M	1.61 M	1.75 M	1.9 M	2.04 M	2.17 M	-	2.44 M	2.57 M	2.69 M	6 K	8 K	9 K	9 K	9 K	9 K	861 K	861 K	861 K	861 K	-	-	-	-	-	-	-	12.7 M	14.2 M	14.2 M	14.2 M	14.2 M	11.2 M	11.2 M	11.2 M	11.2 M	13.1 M	13.1 M	13.1 M	13.1 M	323 K	323 K	323 K	323 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	13.1 M	11.9 M	10.6 M	10.9 M	10 M	9.85 M	10.4 M	-	9.1 M	9.13 M	7.77 M	4.82 M	4.76 M	6.57 M	6.57 M	6.57 M	6.57 M	5.78 M	5.78 M	5.78 M	5.78 M	4.09 M	4.09 M	4.09 M	4.09 M	5.78 M	5.78 M	5.78 M	5.78 M	24.2 M	24.2 M	24.2 M	24.2 M	22.7 M	22.7 M	22.7 M	22.7 M	20.5 M	20.5 M	20.5 M	20.5 M	6.76 M	6.76 M	6.76 M	6.76 M	9.5 M	9.5 M	9.5 M	9.5 M	5.27 M	5.27 M	5.27 M	5.27 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-349 M	-340 M	-330 M	-320 M	-309 M	-298 M	-290 M	-	-271 M	-260 M	-250 M	-243 M	-237 M	-231 M	-231 M	-231 M	-231 M	-209 M	-209 M	-209 M	-209 M	-192 M	-192 M	-192 M	-192 M	-173 M	-173 M	-173 M	-173 M	-148 M	-148 M	-148 M	-148 M	-109 M	-109 M	-109 M	-109 M	-81.4 M	-81.4 M	-81.4 M	-81.4 M	-67 M	-67 M	-67 M	-67 M	-55.2 M	-55.2 M	-55.2 M	-55.2 M	-43.6 M	-43.6 M	-43.6 M	-43.6 M
Total Assets	74 M	81.6 M	88.5 M	97.5 M	107 M	116 M	124 M	-	139 M	150 M	141 M	144 M	130 M	135 M	135 M	135 M	135 M	13.1 M	13.1 M	13.1 M	13.1 M	14.2 M	14.2 M	14.2 M	14.2 M	12.3 M	12.3 M	12.3 M	12.3 M	44 M	44 M	44 M	44 M	71.4 M	71.4 M	71.4 M	71.4 M	28.9 M	28.9 M	28.9 M	28.9 M	27.2 M	27.2 M	27.2 M	27.2 M	11.7 M	11.7 M	11.7 M	11.7 M	1.04 M	1.04 M	1.04 M	1.04 M
Cash and Cash Equivalents	18.7 M	21.7 M	15.2 M	19.4 M	15 M	16.3 M	18.7 M	21 M	20.1 M	11.9 M	13.2 M	10.6 M	14.7 M	131 M	131 M	131 M	131 M	10.2 M	10.2 M	10.2 M	10.2 M	11.5 M	11.5 M	11.5 M	11.5 M	8.23 M	8.23 M	8.23 M	8.23 M	13.9 M	13.9 M	13.9 M	13.9 M	67.5 M	67.5 M	67.5 M	67.5 M	67.5 M	27.3 M	27.3 M	27.3 M	25.8 M	25.8 M	25.8 M	25.8 M	10.8 M	10.8 M	10.8 M	10.8 M	700 K	700 K	700 K	700 K
Book Value	60.9 M	69.7 M	77.8 M	86.6 M	96.5 M	106 M	113 M	-	130 M	140 M	134 M	139 M	125 M	128 M	128 M	128 M	128 M	7.31 M	7.31 M	7.31 M	7.31 M	10.1 M	10.1 M	10.1 M	10.1 M	6.51 M	6.51 M	6.51 M	6.51 M	19.8 M	19.8 M	19.8 M	19.8 M	48.7 M	48.7 M	48.7 M	48.7 M	8.35 M	8.35 M	8.35 M	8.35 M	20.4 M	20.4 M	20.4 M	20.4 M	2.17 M	2.17 M	2.17 M	2.17 M	-4.23 M	-4.23 M	-4.23 M	-4.23 M
Total Shareholders Equity	60.9 M	69.7 M	77.8 M	86.6 M	96.5 M	106 M	113 M	120 M	130 M	140 M	134 M	139 M	125 M	128 M	128 M	128 M	128 M	7.31 M	7.31 M	7.31 M	7.31 M	10.1 M	10.1 M	10.1 M	10.1 M	6.51 M	6.51 M	6.51 M	6.51 M	19.8 M	19.8 M	19.8 M	19.8 M	48.7 M	48.7 M	48.7 M	48.7 M	8.35 M	8.35 M	8.35 M	8.35 M	20.4 M	20.4 M	20.4 M	20.4 M	2.17 M	2.17 M	2.17 M	2.17 M	-4.23 M	-4.23 M	-4.23 M	-4.23 M

All numbers in USD currency